Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2023 Annual Meeting | C191 - Neurological Complications of Checkpoint Inhibitors

Thursday 04/27/23
07:00 AM - 09:00 AM EST Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Jorg Dietrich, MD, PhD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Participants should gain an understanding of potential neurotoxic side effects of novel immunotherapies, including immune checkpoint inhibitors and CAR-T cells; recognize clinical and imaging patterns of neurotoxicity after immunotherapy; and discuss current management options and identify strategies designed to improve patient outcome.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:30 AM EST Speaker Immunotherapy Associated Complications: Case Presentations from Clinical Practice
Amanda C. Guidon, MD
07:30 AM - 08:00 AM EST Speaker Checkpoint-inhibitor Associated Peripheral Nervous System Complications
Leonie Carolin Muller-Jensen, MD
08:00 AM - 08:30 AM EST Speaker Checkpoint-inhibitor Associated Central Nervous System Complications
James Michael Hillis, MD
08:30 AM - 09:00 AM EST Speaker CAR-T Cell Associated Neurological Complications
Jorg Dietrich, MD, PhD, FAAN
Faculty Disclosures
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Amanda C. Guidon, MD An immediate family member of Dr. Guidon has received personal compensation for serving as an employee of GE Healthcare. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Momenta. Dr. Guidon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Guidon has received research support from MGFA. The institution of Dr. Guidon has received research support from Project Data Sphere. The institution of Dr. Guidon has received research support from MGNet. The institution of Dr. Guidon has received research support from MGNet. Dr. Guidon has received publishing royalties from a publication relating to health care.
James Michael Hillis, MD Dr. Hillis has stock in Elly Health. The institution of Dr. Hillis has received research support from GE Healthcare. The institution of Dr. Hillis has received research support from Annalise.ai. The institution of Dr. Hillis has received research support from Viz.ai. Dr. Hillis has received intellectual property interests from a discovery or technology relating to health care.
Leonie Carolin Muller-Jensen, MD Dr. Muller-Jensen has nothing to disclose.